| Rosinda De La Pena, MD | |
|
9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 | |
| (525) 805-4777 | |
| (414) 805-4774 |
| Full Name | Rosinda De La Pena |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215464359 | NPI | - | NPPES |
| 1215464359 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 75100 (Wisconsin) | Primary |
| Entity Name | The Medical College Of Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. In an article published in Nature Immunology, the scientists show that, in combination with existing immunotherapies, this process efficiently destroys cancer cells.
SinoVeda Canada Inc. today announces positive clinical results for EffectiCal® from its 24-week double-blind, randomized comparative clinical trial in post-menopausal women.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.
Teva Women's Health, Inc., a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the U.S. Food and Drug Administration has accepted for filing its New Drug Application for Quartette (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets).
We face a severe financial crisis of unprecedented dimensions in a world that has never before been so closely connected and interdependent. The consequences are global. The situation is volatile. The current financial crisis is rapidly becoming an economic crisis and threatens to become a social crisis in many countries.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosinda De La Pena, MD 9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 Ph: (414) 805-4777 | Rosinda De La Pena, MD 9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 Ph: (525) 805-4777 |
News Archive
Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. In an article published in Nature Immunology, the scientists show that, in combination with existing immunotherapies, this process efficiently destroys cancer cells.
SinoVeda Canada Inc. today announces positive clinical results for EffectiCal® from its 24-week double-blind, randomized comparative clinical trial in post-menopausal women.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.
Teva Women's Health, Inc., a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the U.S. Food and Drug Administration has accepted for filing its New Drug Application for Quartette (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets).
We face a severe financial crisis of unprecedented dimensions in a world that has never before been so closely connected and interdependent. The consequences are global. The situation is volatile. The current financial crisis is rapidly becoming an economic crisis and threatens to become a social crisis in many countries.
› Verified 2 days ago
Dr. Dwight P Cruikshank, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9200 W Wisconsin Ave, Froedtert & Med College Clin - East, Milwaukee, WI 53226 Phone: 414-805-3666 | |
Kristine R. Graettinger, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6600 Fax: 414-805-6622 | |
Mrs. Helena M Coke, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 'none', Milwaukee, WI 53224 Phone: 414-760-2934 | |
Paul Ginkel, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 930 W Historic Mitchell St, Milwaukee, WI 53204 Phone: 414-383-9526 Fax: 414-389-3881 | |
Colleen Anne Keane-mullooly, RNC,MS,WHNP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 302 N Jackson St, Milwaukee, WI 53202 Phone: 608-347-2297 | |
Amy Marie Rider, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7878 N 76th St, Milwaukee, WI 53223 Phone: 414-354-6434 | |
Jessica A Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Maternal And Fetal Medicine, Milwaukee, WI 53226 Phone: 414-805-6624 Fax: 414-805-9000 |